Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-26 @ 3:18 PM
NCT ID:
NCT07357194
Brief Summary:
The primary purpose of this study is to identify and analyze the barriers to renal rehabilitation among patients diagnosed with kidney failure in Cairo
Detailed Description:
This study is a cross-sectional design aimed at identifying the barriers to renal rehabilitation among patients diagnosed with kidney failure in governemtnal hospitals in Cairo.
The sample size for this study was determined using G\*POWER statistical software (version 3.1.9.2; Franz Faul, Universitat Kiel, Germany) and was based on a previous study by (Bossola et al., 2014). which reported a prevalence of 38.1%. The required sample size calculated for this study is N=155, with calculations made using a significance level (α) of 0.05 and a statistical power of 80%. This sample size is deemed appropriate for achieving the study's objectives and ensuring statistically significant results.
155 patients suffering from kidney failure will participate in the study. They will be selected randomly from the different governmental hospitals centers in Cairo, Informed consent Freely and voluntarily consent to participate in this research study (Effect of pelvic floor down-training exercise on females with idiopathic overactive bladder) under the supervision and direction of the researcher/ Merna Mabrouk A thorough description of the study procedures has been explained to me, and I understand that I may withdraw my consent and discontinue participation in this study research at any time without prejudice to me.
Study:
NCT07357194
Study Brief:
Protocol Section:
NCT07357194